HNGE insider sells 15,000 shares for $590K

James Pursley reported a sale of 15,000 common shares.

Rhea-AI Filing Summary

James Pursley reported a sale of 15,000 common shares. The filing shows 15,000 shares sold under a 10b5-1 plan on 02/23/2026 for $589,983. The securities originated as Performance Stock Units granted 04/01/2023 and the broker listed is Morgan Stanley Smith Barney LLC. The notice was filed on 03/23/2026.

Insights

Equity Transactions Analyst

10b5-1 sale of 15,000 shares by James Pursley reported; proceeds shown as $589,983.

The report states a 10b5-1 sale executed on 02/23/2026 for $589,983, affecting 15,000 common shares that trace to Performance Stock Units dated 04/01/2023. The broker listed is Morgan Stanley Smith Barney LLC.

Timing and pricing are supplied in the excerpt; cash‑flow recipient is the selling holder per the 10b5-1 sale. Subsequent filings may disclose any remaining holding amounts or additional plan details.

Corporate Governance Advisor

Sale executed under a pre-arranged trading plan, indicating an orderly disposition rather than a discretionary open-market decision.

The filing explicitly labels the transaction as a 10b5-1 sale, which is typically a pre-established plan for insiders to sell shares. The listed grant origin is Performance Stock Units dated 04/01/2023.

Documented broker involvement and the filing date 03/23/2026 complete the disclosure; the excerpt does not state post-transaction holdings or additional plan terms.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did James Pursley report in the Form 144 for HNGE?

He reported selling 15,000 common shares under a 10b5-1 plan on 02/23/2026. The filing shows proceeds of $589,983 and lists Morgan Stanley Smith Barney LLC as the broker.

Were the sold shares part of an award or grant for HNGE?

Yes — the filing ties the securities to Performance Stock Units granted on 04/01/2023. The excerpt lists the grant date and 15,000 shares as the instrument origin.

What proceeds were reported for the 15,000-share sale?

The excerpt reports aggregate proceeds of $589,983 for the sale executed on 02/23/2026. A separate figure of $637,200 appears in the form fields but the sale line shows $589,983.

Investors should rely on the specific sale row as the transaction amount.

Which broker handled the reported transaction?

The filing lists Morgan Stanley Smith Barney LLC (New York Plaza) as the broker for the transaction. The broker and address are provided on the form's securities-to-be-sold section.

When was the Form 144 notice filed for this sale?

The notice in the excerpt is dated 03/23/2026. The underlying 10b5-1 sale occurred on 02/23/2026, as shown in the sold-during-the-past-3-months row.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 04:34 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES PURSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	637200.00	55816216	03/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2023	Performance Stock Units	Issuer			15000	04/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco CA 94105	Common	02/23/2026	15000	589983.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of performance stock units during the period of 4/1/2023 through 3/31/2025.
Date of Notice	03/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Pursley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)